Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lloyd Pereira

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|May 23, 2013
Myb and the regulation of stem cells in the intestine and brain: a tale of two nichesJordane Malaterre, Lloyd Pereira, Robert G Ramsay
Frontiers in Oncology|February 21, 2015
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancerLloyd Pereira, John M Mariadason, Ross D Hannan, et al.
Stem Cells (Dayton, Ohio)|October 15, 2011
Myb controls intestinal stem cell genes and self-renewalDane Cheasley, Lloyd Pereira, Sally Lightowler, et al.
Annals of Surgical Oncology|July 25, 2018
An Update on Immunotherapy for Solid Tumors: A ReviewToan Pham, Sara Roth, Joseph Kong, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 10, 2019
Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical ModelToan Pham, Sandra Carpinteri, Shienny Sampurno, et al.
Cancer Research|September 28, 2011
MYB is essential for mammary tumorigenesisRebecca Yu Miao, Yvette Drabsch, Ryan Stanley Cross, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Enforced expression of Mixl1 during mouse ES cell differentiation suppresses hematopoietic mesoderm and promotes endoderm formationSue Mei Lim, Lloyd Pereira, Michael S Wong, et al.
Contemporary Clinical Trials Communications|October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)Toan Pham, Lloyd Pereira, Sara Roth, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|May 23, 2013
Myb and the regulation of stem cells in the intestine and brain: a tale of two nichesJordane Malaterre, Lloyd Pereira, Robert G Ramsay
Frontiers in Oncology|February 21, 2015
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancerLloyd Pereira, John M Mariadason, Ross D Hannan, et al.
Stem Cells (Dayton, Ohio)|October 15, 2011
Myb controls intestinal stem cell genes and self-renewalDane Cheasley, Lloyd Pereira, Sally Lightowler, et al.
Annals of Surgical Oncology|July 25, 2018
An Update on Immunotherapy for Solid Tumors: A ReviewToan Pham, Sara Roth, Joseph Kong, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 10, 2019
Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical ModelToan Pham, Sandra Carpinteri, Shienny Sampurno, et al.
Cancer Research|September 28, 2011
MYB is essential for mammary tumorigenesisRebecca Yu Miao, Yvette Drabsch, Ryan Stanley Cross, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Enforced expression of Mixl1 during mouse ES cell differentiation suppresses hematopoietic mesoderm and promotes endoderm formationSue Mei Lim, Lloyd Pereira, Michael S Wong, et al.
Contemporary Clinical Trials Communications|October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)Toan Pham, Lloyd Pereira, Sara Roth, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
Pageof 2